Chiara Ruzza

2.2k total citations
61 papers, 1.1k citations indexed

About

Chiara Ruzza is a scholar working on Cellular and Molecular Neuroscience, Molecular Biology and Physiology. According to data from OpenAlex, Chiara Ruzza has authored 61 papers receiving a total of 1.1k indexed citations (citations by other indexed papers that have themselves been cited), including 56 papers in Cellular and Molecular Neuroscience, 36 papers in Molecular Biology and 18 papers in Physiology. Recurrent topics in Chiara Ruzza's work include Neuropeptides and Animal Physiology (55 papers), Receptor Mechanisms and Signaling (35 papers) and Sleep and Wakefulness Research (16 papers). Chiara Ruzza is often cited by papers focused on Neuropeptides and Animal Physiology (55 papers), Receptor Mechanisms and Signaling (35 papers) and Sleep and Wakefulness Research (16 papers). Chiara Ruzza collaborates with scholars based in Italy, Brazil and United States. Chiara Ruzza's co-authors include Girolamo Calò, Remo Guerrini, Severo Salvadori, Anna Rizzi, A. Rizzi, Elaine C. Gavioli, Claudio Trapella, D. Regoli, Giuliano Marzola and Rainer K. Reinscheid and has published in prestigious journals such as Pain, International Journal of Molecular Sciences and Journal of Medicinal Chemistry.

In The Last Decade

Chiara Ruzza

57 papers receiving 1.1k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Chiara Ruzza Italy 19 921 546 365 257 231 61 1.1k
Amalia Fedeli Italy 10 633 0.7× 378 0.7× 112 0.3× 194 0.8× 172 0.7× 16 844
Giuliano Marzola Italy 25 1.5k 1.6× 1.2k 2.1× 215 0.6× 544 2.1× 177 0.8× 36 1.7k
Valérie Compan France 21 853 0.9× 539 1.0× 210 0.6× 180 0.7× 199 0.9× 39 1.4k
Linda M. Rorick‐Kehn United States 14 636 0.7× 421 0.8× 187 0.5× 131 0.5× 127 0.5× 14 866
Alessandra Oberto Italy 18 561 0.6× 335 0.6× 100 0.3× 78 0.3× 194 0.8× 39 874
Robert T. Matthews United States 19 827 0.9× 470 0.9× 341 0.9× 134 0.5× 262 1.1× 32 1.3k
Thierry Jolas United States 18 849 0.9× 488 0.9× 222 0.6× 240 0.9× 98 0.4× 24 1.2k
Ilga Misane Sweden 17 622 0.7× 394 0.7× 286 0.8× 80 0.3× 104 0.5× 21 945
Michael J. Kuhar United States 19 729 0.8× 432 0.8× 158 0.4× 478 1.9× 739 3.2× 24 1.5k
Rick L. Pieschl United States 14 513 0.6× 228 0.4× 468 1.3× 193 0.8× 877 3.8× 25 1.3k

Countries citing papers authored by Chiara Ruzza

Since Specialization
Citations

This map shows the geographic impact of Chiara Ruzza's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Chiara Ruzza with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Chiara Ruzza more than expected).

Fields of papers citing papers by Chiara Ruzza

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Chiara Ruzza. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Chiara Ruzza. The network helps show where Chiara Ruzza may publish in the future.

Co-authorship network of co-authors of Chiara Ruzza

This figure shows the co-authorship network connecting the top 25 collaborators of Chiara Ruzza. A scholar is included among the top collaborators of Chiara Ruzza based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Chiara Ruzza. Chiara Ruzza is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Pola, P., Salvatore Pacifico, Valentina Erminia Albanese, et al.. (2025). Sex differences in response to NLRP3 inflammasome blockage in a mouse migraine model: A genetic and pharmacological study. Biomedicine & Pharmacotherapy. 191. 118411–118411.
2.
Pola, P., Matilde Marini, Francesco De Logu, et al.. (2025). Activation of peripheral NOP receptors reduces periorbital mechanical allodynia evoked by CGRP in mice. British Journal of Pharmacology.
3.
Albanese, Valentina Erminia, Matilde Marini, M. Tesi, et al.. (2025). Identification of isoxazole-based TRPA1 inhibitors with analgesic effects in vivo. European Journal of Medicinal Chemistry. 294. 117732–117732.
4.
Ruzza, Chiara, Federica Ferrari, P. Pola, et al.. (2024). In vitro pharmacological characterization of growth hormone secretagogue receptor ligands using the dynamic mass redistribution and calcium mobilization assays. European Journal of Pharmacology. 981. 176880–176880. 1 indexed citations
5.
Aziz, Nimra, Chiara Ruzza, Chiara Falcicchia, et al.. (2024). Lack of Direct Effects of Neurotrophic Factors in an In Vitro Model of Neuroinflammation. International Journal of Molecular Sciences. 25(8). 4160–4160. 1 indexed citations
6.
7.
Targowska‐Duda, Katarzyna M., Jennifer J. Schoch, Chiara Ruzza, et al.. (2023). Preclinical effects of cannabidiol in an experimental model of migraine. Pain. 164(11). 2540–2552. 9 indexed citations
8.
Gavioli, Elaine C., et al.. (2022). The NOP antagonist BTRX-246040 increases stress resilience in mice without affecting adult neurogenesis in the hippocampus. Neuropharmacology. 212. 109077–109077. 8 indexed citations
9.
Gentilucci, Luca, Chiara Ruzza, Girolamo Calò, et al.. (2022). Synthesis, Biological Activity and Molecular Docking of Chimeric Peptides Targeting Opioid and NOP Receptors. International Journal of Molecular Sciences. 23(20). 12700–12700. 3 indexed citations
10.
Reinscheid, Rainer K. & Chiara Ruzza. (2021). Pharmacology, Physiology and Genetics of the Neuropeptide S System. Pharmaceuticals. 14(5). 401–401. 10 indexed citations
11.
Costanzini, Anna, Chiara Ruzza, Davide Malfacini, et al.. (2021). Pharmacological characterization of naloxegol: In vitro and in vivo studies. European Journal of Pharmacology. 903. 174132–174132. 3 indexed citations
12.
Ruzza, Chiara, et al.. (2021). Functional Selectivity Does Not Predict Antinociceptive/Locomotor Impairing Potencies of NOP Receptor Agonists. Frontiers in Neuroscience. 15. 657153–657153. 8 indexed citations
13.
Costanzini, Anna, et al.. (2020). Biased versus Partial Agonism in the Search for Safer Opioid Analgesics. Molecules. 25(17). 3870–3870. 60 indexed citations
14.
Ferrari, Federica, Sabrina Rizzo, Chiara Ruzza, & Girolamo Calò. (2020). Detailed In Vitro Pharmacological Characterization of the Clinically Viable Nociceptin/Orphanin FQ Peptide Receptor Antagonist BTRX-246040. Journal of Pharmacology and Experimental Therapeutics. 373(1). 34–43. 13 indexed citations
15.
Gavioli, Elaine C., et al.. (2018). NOP Ligands for the Treatment of Anxiety and Mood Disorders. Handbook of experimental pharmacology. 254. 233–257. 21 indexed citations
16.
Asth, Laila, et al.. (2018). NOP agonists prevent the antidepressant-like effects of nortriptyline and fluoxetine but not R-ketamine. Psychopharmacology. 235(11). 3093–3102. 24 indexed citations
17.
Cerlesi, Maria Camilla, Huiping Ding, Norikazu Kiguchi, et al.. (2016). Pharmacological studies on the NOP and opioid receptor agonist PWT2-[Dmt1]N/OFQ(1-13). European Journal of Pharmacology. 794. 115–126. 23 indexed citations
18.
Ruzza, Chiara, Laila Asth, Remo Guerrini, et al.. (2015). Blockade of nociceptin/orphanin FQ receptor signaling reverses LPS-induced depressive-like behavior in mice. Peptides. 72. 95–103. 32 indexed citations
19.
Ruzza, Chiara, Anna Rizzi, Davide Malfacini, et al.. (2015). In vitro and in vivo pharmacological characterization of Pronetupitant, a prodrug of the neurokinin 1 receptor antagonist Netupitant. Peptides. 69. 26–32. 7 indexed citations
20.
Trapella, Claudio, Girolamo Calò, Valeria Camarda, et al.. (2011). Synthesis and Separation of the Enantiomers of the Neuropeptide S Receptor Antagonist (9R/S)-3-Oxo-1,1-diphenyl-tetrahydro-oxazolo[3,4-a]pyrazine-7-carboxylic Acid 4-Fluoro-benzylamide (SHA 68). Journal of Medicinal Chemistry. 54(8). 2738–2744. 19 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Amalia Fedeli Breakdown of academic impact, for papers by Giuliano Marzola Breakdown of academic impact, for papers by Valérie Compan Breakdown of academic impact, for papers by Linda M. Rorick‐Kehn Breakdown of academic impact, for papers by Alessandra Oberto Breakdown of academic impact, for papers by Robert T. Matthews Breakdown of academic impact, for papers by Thierry Jolas Breakdown of academic impact, for papers by Ilga Misane Breakdown of academic impact, for papers by Michael J. Kuhar Breakdown of academic impact, for papers by Rick L. Pieschl
Rankless by CCL
2026